Replies to post #24121 on Can B Corp (CANB)

[LastCawl]

Finally. Thanks for the concise posts!

[sleekscape]

My last post left for today...and I didn't mean to over-discuss on a Friday, but that list of problems with THC is no good.

You can say that THC has short term negative effects on short term memory, but we both know THC is not anywhere near as harmful as plenty of legally ingestible substances. We also know it has medical benefits, or it wouldn't be an ingredient in those FDA approved drugs you listed. Furthermore, the .3% THC that naturally occurs in hemp is so far below any level of psycho-activity, that citing such a risk comes off as a scare tactic.

The key to predicting the future is sourcing primary data from the parties who will be the decision-makers

My personal opinion is that Full Spectrum CBD Oil products (Supplements and Foods) should be federally legalized by Congress, but what I feel or think should happen is irrelevant

That is why I am providing you this link to comments Dr. Gottlieb made in September 2019 on THC in CBD products — his language is very strong and direct and speaks for itself:

https://www.aei.org/research-products/speech/delivering-remarks-on-cannabinoids-gottlieb-at-samford-university-mcwhorter-school-of-pharmacy/

“The Food and Drug Administration has always been supportive of responsible research into the active ingredients of cannabis. But marijuana is still a Schedule I compound with known risks. That scheduling reflects proper concerns around the effects of THC.

These risks prompted my former colleague, the U.S. Surgeon General Jerome Adams – just this month – to issue a rare public health warning that no amount of THC is safe for teens, young adults and pregnant women.

THC has significant risks associated with infrequent and especially regular use.

Currently marketed products may have undeclared ingredients and impurities, including THC.

When Congress passed the Farm Bill, many expected that it would create a legal path for CBD to be widely sold in food products like dietary supplements. Some farmers say that the CBD oil from hemp is a high margin derivative from that crop. And to make the growing of hemp economically viable, farmers need to be able to extract and sell CBD from hemp.

We need a framework that not only differentiates THC from CBD, but one that also creates a safe and legal path to contemplate the addition of CBD to food and dietary supplements.

In tackling the continued marketing of CBD head on, FDA could enforce compliance with traceability and good manufacturing practice, which would help address concerns about undeclared ingredients and the presence of THC.”

As far as investing ahead of what you think the FDA will do, well, there is what they wanna do, and what they gotta do. The FDA were commissioned by the Farm Bill to regulate Hemp, not CBD. Are they doing that?

“there is what they wanna do, and what they gotta do”

Congress isn’t the only party directing and influencing the FDA with respect to regulating Hemp and its cannabinoids

The pharmaceutical lobby is extremely powerful and must be taken into account here

It’s an open secret in DC that the deal currently on the table from the pharmaceutical lobby is to make a singular exception for CBD and leave the other cannabinoids for the pharma industry — whether other cannabinoids like CBG, CBN and CBC are subject to the IND preclusion is not a settled issue from their perspective

But, after the FDA has just proclaimed the IND preclusion for CBD as the whole basis for disqualifying it from food and dietary supplements, I think depriving consumers of other non-psychoactive secondary cannabinoids simply because they HAVEN'T been part of any safety studies meant for FDA approved drugs would be self-contradictory at a minimum.

The IND preclusion for CBD is not the “whole basis” for disqualifying it from food and dietary supplements

It is only part of it

There are two other significant aspects that are in play here — both have been stated many times publicly by the FDA since The 2018 Farm Bill was passed

1) Safety data required to add CBD to food and dietary supplements

2) Preserving incentives for the pharmaceutical industry to continue pouring money into researching CBD and making medical progress

There is nothing stopping any secondary cannabinoids from going into food or dietary supplements as they are not FDA drug ingredients. So if/when CBD gets a green light, the others will all legally come along for the ride.

As I’ve just stated, there are 3 different significant factors that will determine whether other cannabinoids outside of CBD will be permitted by the FDA into food or dietary supplements and all 3 factors are currently working against them

1) IND preclusion — the FDA hasn’t publicly commented on this as of yet, but this is not a settled issue for many of the other cannabinoids which have been studied for a number of years

2) Safety Data — there is far more safety data on CBD than on CBG, CBC, CBN, etc

So if the FDA still isn’t satisfied with the safety data on CBD, where does that leave the other cannabinoids?

3) Preserving incentives for pharma to perform research on CBG, CBC, CBN, etc

Congress passed the Farm Bill with the definition of .3% THC in it, so when it comes to passing a hemp derived CBD dietary supplement bill, congress shouldn't have an issue with .3% THC. It is not the FDA passing the legislation, so their feelings about THC wont matter.

“It is not the FDA passing the legislation, so their feelings about THC wont matter.”

I don’t even know where to begin with this argument

The FDA’s feelings about THC are very strong

And so are their facts

Facts certainly matter

Anyway, I'm out of posts. Have a good weekend. GL!

Have a great weekend and good luck with your investments!


Sleek